CMG Pharmaceutical Co. Ltd (058820) — Long-term Investment Intensity
CMG Pharmaceutical Co. Ltd (058820) has a Long-term Investment Intensity of 2.1% as of September 2019. Long-term investments of ₩4.15 Billion represent 2.1% of total assets of ₩193.09 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 058820 financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
CMG Pharmaceutical Co. Ltd Long-term Investment Intensity (2014–2018)
This chart shows how CMG Pharmaceutical Co. Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of September 2019, the intensity stands at 2.1%, reflecting long-term investments of ₩4.15 Billion against total assets of ₩193.09 Billion KRW. For the complete balance sheet picture, see 058820 total asset value.
Annual Long-term Investment Intensity for CMG Pharmaceutical Co. Ltd (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for CMG Pharmaceutical Co. Ltd from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read CMG Pharmaceutical Co. Ltd total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 4.1% | ₩4.66 Billion | ₩114.38 Billion | ▲ +0.3 pp |
| 2017 | 3.8% | ₩4.15 Billion | ₩109.57 Billion | ▲ +2.6 pp |
| 2016 | 1.2% | ₩1.30 Billion | ₩110.98 Billion | ▲ +0.8 pp |
| 2015 | 0.4% | ₩202.00 Million | ₩56.53 Billion | ▲ +0.0 pp |
| 2014 | 0.3% | ₩202.00 Million | ₩58.07 Billion | — |